Pipeline & Clinical Trials

Pipeline at a Glance

Sumitomo Pharma America, Inc. is advancing a portfolio of investigational therapies across multiple areas, including oncology, central nervous system (CNS), and regenerative medicine. Our research and development efforts focus on targeted small molecules and emerging modalities designed to address areas of unmet medical need.

  • 10

    Pipeline Molecules

    Under Investigation

  • 7

    Active Clinical Trials

    Across Various Phases

  • 5

    Recruiting Participants

    Open for Enrollment

No results match the selected filters.

Expanded Access Program

Sumitomo Pharma America, Inc. may consider access to investigational products outside of clinical trials for eligible patients who have no alternative treatment options.

View Expanded Access Program

Contact Us

Connect with an MSL

Find a Medical Science Liaison (MSL) in your region and specialty.

Stay up to date

Sign up to receive the latest clinical data, scientific resources and news from Sumitomo Pharma America Medical Affairs.